Erlandsen H - Search Results

1

Mechanisms underlying responsiveness to tetrahydrobiopterin in mild phenylketonuria mutations.

Pey AL, Pérez B, Desviat LR, Martínez MA, Aguado C, Erlandsen H, Gámez A, Stevens RC, Thórólfsson M, Ugarte M, Martínez A. Pey AL, et al. Among authors: erlandsen h. Hum Mutat. 2004 Nov;24(5):388-99. doi: 10.1002/humu.20097. Hum Mutat. 2004. PMID: 15459954

2

Correction of kinetic and stability defects by tetrahydrobiopterin in phenylketonuria patients with certain phenylalanine hydroxylase mutations.

Erlandsen H, Pey AL, Gámez A, Pérez B, Desviat LR, Aguado C, Koch R, Surendran S, Tyring S, Matalon R, Scriver CR, Ugarte M, Martínez A, Stevens RC. Erlandsen H, et al. Proc Natl Acad Sci U S A. 2004 Nov 30;101(48):16903-8. doi: 10.1073/pnas.0407256101. Epub 2004 Nov 19. Proc Natl Acad Sci U S A. 2004. PMID: 15557004 Free PMC article.

3

The structural basis of phenylketonuria.

Erlandsen H, Stevens RC. Erlandsen H, et al. Mol Genet Metab. 1999 Oct;68(2):103-25. doi: 10.1006/mgme.1999.2922. Mol Genet Metab. 1999. PMID: 10527663 Review.

4

A structural hypothesis for BH4 responsiveness in patients with mild forms of hyperphenylalaninaemia and phenylketonuria.

Erlandsen H, Stevens RC. Erlandsen H, et al. J Inherit Metab Dis. 2001 Apr;24(2):213-30. doi: 10.1023/a:1010371002631. J Inherit Metab Dis. 2001. PMID: 11405341 Review.

5

Structural studies on phenylalanine hydroxylase and implications toward understanding and treating phenylketonuria.

Erlandsen H, Patch MG, Gamez A, Straub M, Stevens RC. Erlandsen H, et al. Pediatrics. 2003 Dec;112(6 Pt 2):1557-65. Pediatrics. 2003. PMID: 14654665 Review.

6

Trends in enzyme therapy for phenylketonuria.

Kim W, Erlandsen H, Surendran S, Stevens RC, Gamez A, Michols-Matalon K, Tyring SK, Matalon R. Kim W, et al. Among authors: erlandsen h. Mol Ther. 2004 Aug;10(2):220-4. doi: 10.1016/j.ymthe.2004.05.001. Mol Ther. 2004. PMID: 15294168 Free article. Review.

7

Biopterin responsive phenylalanine hydroxylase deficiency.

Matalon R, Koch R, Michals-Matalon K, Moseley K, Surendran S, Tyring S, Erlandsen H, Gamez A, Stevens RC, Romstad A, Møller LB, Guttler F. Matalon R, et al. Among authors: erlandsen h. Genet Med. 2004 Jan-Feb;6(1):27-32. doi: 10.1097/01.gim.0000108840.17922.a7. Genet Med. 2004. PMID: 14726806 Clinical Trial.

8

Crystal structure of the catalytic domain of human phenylalanine hydroxylase reveals the structural basis for phenylketonuria.

Erlandsen H, Fusetti F, Martinez A, Hough E, Flatmark T, Stevens RC. Erlandsen H, et al. Nat Struct Biol. 1997 Dec;4(12):995-1000. doi: 10.1038/nsb1297-995. Nat Struct Biol. 1997. PMID: 9406548 Review.

9

Structure of tetrameric human phenylalanine hydroxylase and its implications for phenylketonuria.

Fusetti F, Erlandsen H, Flatmark T, Stevens RC. Fusetti F, et al. Among authors: erlandsen h. J Biol Chem. 1998 Jul 3;273(27):16962-7. doi: 10.1074/jbc.273.27.16962. J Biol Chem. 1998. PMID: 9642259 Free article.

10

Structural comparison of bacterial and human iron-dependent phenylalanine hydroxylases: similar fold, different stability and reaction rates.

Erlandsen H, Kim JY, Patch MG, Han A, Volner A, Abu-Omar MM, Stevens RC. Erlandsen H, et al. J Mol Biol. 2002 Jul 12;320(3):645-61. doi: 10.1016/s0022-2836(02)00496-5. J Mol Biol. 2002. PMID: 12096915

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page